Shouguang fukang pharmaceutical Co., Ltd. Founded in 1993, shouguang fukang is a premier research and technology driven Chinese pharmaceutical enterprise with demonstrated capabilities for new drug research and development. It is ranked 42ND among china's pharmaceutical industry, employs 3, 000 people and has a manufacturing campus of over 300 acres (2, 000 Chinese acre).

Shouguang fukang pharmaceutical Co., Ltd. Specializes in the development, manufacturing and marketing of 5 core product categories. They are pharmaceutcal API, intermedites and finished dose as well as bromide compounds and paper additives, with a total of more than 60 products. Our production and sales volume of the API, trimethoprim (tmp), accounts for more than 70% of the world market. We are the no. 1 domestic producer and marketer of omeprazole, and metformin HCl and the largest production base of bromide compounds. In a joint venture with basf, we produce the following paper additives; Odb-ii, odb-I, s-205 and egte, to the highest international standards.